【摘 要】
：
The purpose of this presentation is to review the investigations since 2001 carried out in my laboratory employing a new, non-invasive technology called Whole Body Periodic Acceleration (WBPA or pGz)
【机 构】
：
Division of Neonatology Mt Sinai Medical Center USA
【出 处】
：
BITs 2rd Annual World Cancer Congress of Cardiology-2010(201
论文部分内容阅读
The purpose of this presentation is to review the investigations since 2001 carried out in my laboratory employing a new, non-invasive technology called Whole Body Periodic Acceleration (WBPA or pGz) in the management of global and localized, cardiac ischemia reperfusion injury.Because WBPA increases pulsatile shear stress onto the endothelium,it provides a plethora of cardioprotective measures either directly or through up-regulating genes or by affecting transcription factors as a result of release of mediators from the endothelium.
其他文献
Background— High-density lipoprotein (HDL) helps to protect against atherosclerosis, not only by enhancing reverse cholesterol transport but also due to its anti-oxidative and anti-inflammatory proper
A number of pathological eonditions, including chronic inflammation, generate conditions where low density lipoprotein (LDL) suffers oxidative, chemical and biological changes, thus producing modified
Lipoprotein-associated phospholipase A2 (Lp-PLA2) is today considered a novel specific vascular inflammatory biomarker.Specific aims for this study were to explore the association of Lp-PLA2 with trad
Cardiovascular disease remains the main cause of mortality and morbidity in subjects with diabetes.Moreover, the majority of individuals with cardiac ischemia display abnormalities in glucose metaboli
The purpose of this presentation is to review the beginnings of a new, non-invasive technology called Whole Body Periodic Acceleration (WBPA or pGz) that was discovered serendipitously as a result of
Periodic acceleration in the direction of the spinal axis through repetitive movements increases shear stress to the vascular endothelium.We assessed whether whole-body periodic acceleration with a ne
Whole-body periodic acceleration (WBPA) by using Acceleration Therapeutics (AT101, USA) is reported to up-regulate endothelial nitric oxide (NO) synthase (eNOS) in animal studies and to improve brachi
Background.Exercise training is beneficial in the primary and secondary prevention and treatment of coronary artery disease and a widening variety of other chronic diseases.However, moderate aerobic e
Purpose: We hypothesized that treatment with whole body periodic acceleration (WBPA) improves vascular endothelial function, and ameliorates exercise capacity as a result of increased peripheral vasod
Various tachyarrhythmias have become everyday challenge for clinicians caring for infants, children and adults with repaired or palliated congenital heart disease.The risk of atrial or ventricular tac